Unanswered questions on the safety of MDT-U*
Sign Up to like & getrecommendations! Published in 2019 at "Anais Brasileiros de Dermatologia"
DOI: 10.1590/abd1806-4841.20198564
Abstract: Dear Editor, After reading the article “Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach”1 in your esteemed journal, I had several questions skin pigmentation (21.7%) and xerosis (16.9%)… read more here.
Keywords: mdt; safety mdt; questions safety; unanswered questions ... See more keywords